HALITOSIS AS AN ADDITIONAL CLINICAL MARKER OF STREPTOCOCCAL TONSILLITIS IN CHILDREN: OUTPATIENT OBSERVATION

Authors

DOI:

https://doi.org/10.11603/24116-4944.2025.2.15820

Keywords:

halitosis, streptococcal tonsillitis, pediatric diagnosis, group A β-hemolytic streptococcus (GABHS), oral malodor, chronic tonsillitis, rapid antigen test, bacterial pharyngitis, outpatient pediatrics, diagnostic markers

Abstract

The aim of the study – to evaluate the clinical significance of halitosis as a supplementary marker of streptococcal tonsillitis in children aged 3–18, including its correlation with confirmed Group A β-hemolytic streptococcal (GABHS) infection.

Materials and Methods. A total of 279 children presenting with symptoms of acute or chronic tonsillopharyngitis were assessed between January and May 2025. Clinical examination included halitosis evaluation and a rapid antigen test for GABHS. Patients with non-streptococcal or unrelated conditions were excluded.

Results and Discussion. Of 190 children with confirmed streptococcal infection, halitosis was observed in 128 (67.4 %). The symptom was most prevalent in follicular (89.3 %) and lacunar (78.5 %) tonsillitis and during exacerbations of chronic tonsillitis (81 %). Younger children (7–10 years) exhibited the highest prevalence (73.2 %). Halitosis intensity was moderate in 50.8 % and severe in 27.3 % of cases. A strong correlation was found between halitosis and positive rapid streptococcal test results (87.5 % of halitosis cases were GABHS-positive), versus 36 % among viral cases.

Conclusions. Halitosis may be a valuable, easily detectable marker for streptococcal pharyngotonsillitis in children, especially in settings with limited diagnostic tools. Its integration into clinical algorithms could improve early identification of bacterial infections and guide antibiotic prescribing, supporting efforts to reduce antibiotic resistance.

Author Biographies

  • Ya. D. Bondarenko, Kharkiv National Medical University

    student of the Third Faculty of Medicine

     
  • N. O. Shushliapina, Kharkiv National Medical University

    PhD in Medicine, Associate Professor of the Department of Otorhinolaryngology

     

References

1. Yoo, H.J., Jwa, S.K., Kim, D.H., & Ji, Y.J. (2020). Inhibitory effect of Streptococcus salivarius K12 and M18 on halitosis in vitro. Clinical and Experimental Dental Research, 6(2), 207–214. https://doi.org/10.1002/cre2.269.

2. Sikorska-Żuk, M., & Bochnia, M. (2018). Halitosis in children with adenoid hypertrophy. Journal of Breath Research, 12(2), 026011. https://doi.org/10.1088/1752-7163/aa9b3a

3. Bawazir, O.A. (2021). Risk factors, diagnosis, and management of halitosis in children: A comprehensive review. The Journal of Contemporary Dental Practice, 22(8), 959–963.

4. Smith, K.L., Hughes, R., & Myrex, P. (2023). Tonsillitis and tonsilloliths: Diagnosis and management. American Family Physician, 107(1), 35–41.

5. Brant Pinheiro, S.V., de Freitas, V.B., de Castro, G.V., Rufino Madeiro, B.C., de Araújo, S.A., Silva Ribeiro, T.F., & Simões e Silva, A.C. (2022). Acute post-streptococcal glomerulonephritis in children: A comprehensive review. Current Medicinal Chemistry, 29(34), 5543–5559 https://doi.org/10.2174/0929867329666220613103316.

6. Sika-Paotonu, D., Beaton, A., Raghu, A., ... & Fischetti, V.A. (2017). Acute rheumatic fever and rheumatic heart disease. In J.J. Ferretti, D.L. Stevens, & V.A. Fischetti (Eds.), Streptococcus pyogenes: Basic Biology to Clinical Manifestations. University of Oklahoma Health Sciences Center.

7. Gokdogan, O., Catli, T., & Ileri, F. (2015). Halitosis in otorhinolaryngology practice. Iranian Journal of Otorhinolaryngology, 27(79), 145–153.

8. Tungare, S., Zafar, N., & Paranjpe, A.G. (2025). Halitosis. In StatPearls. StatPearls Publishing.

9. Aylıkcı, B.U., & Colak, H. (2013). Halitosis: From diagnosis to management. Journal of Natural Science, Biology and Medicine, 4(1), 14–23. https://doi.org/10.4103/0976-9668.107255.

10. Bondarenko, Y., & Birjukova, M. (2025). Etiopathogenetic mechanisms of recurrent tonsillitis development in children in organized groups. Grail of Science, 49, 1109–1119. https://doi.org/10.36074/grail-of-science.21.02.2025.158.

11. Bondarenko, Y., Zhuravel, Y., & Ognev, V. (2025). Determinants of health in preschool and school-age children: Challenges of recurrent tonsillitis. Grail of Science, 49, 1089–1100. https://doi.org/10.36074/grail-of-science.21.02.2025.157.

12. Yaegaki, K., & Sanada, K. (1992). Biochemical and clinical factors influencing oral malodor in periodontal patients. Journal of Periodontology, 63(9), 783–789. https://doi.org/10.1902/jop.1992.63.9.783.

13. Bondarenko, Y., & Biriukova, M. (2025). Clinical and diagnostic significance of the color and consistency of discharge from the upper and lower respiratory tracts in assessing the bacterial or viral etiology of disease. Young Scientist, 2(133), 25–31. https://doi.org/10.32839/2304-5809/2025-2-133-33.

14. Guntinas-Lichius, O., Geißler, K., Mäkitie, A.A., Ronen, O., Bradley, P.J., Rinaldo, A., ... & Ferlito, A. (2023). Treatment of recurrent acute tonsillitis: A systematic review and clinical practice recommendations. Frontiers in Surgery, 10, 1221932. https://doi.org/10.3389/fsurg.2023.1221932.

15. Sharma, K., Das, S., & Goswami, A. (2022). A study on acute membranous tonsillitis, its different etiologies and its clinical presentation in a tertiary referral centre. Indian Journal of Otolaryngology and Head & Neck Surgery, 74(Suppl. 3), 4543–4548. https://doi.org/10.1007/s12070-021-02572-2.

16. Sidell, D., & Shapiro, N.L. (2012). Acute tonsillitis. Infectious Disorders – Drug Targets, 12(4), 271–276. https://doi.org/10.2174/187152612801319230.

17. Windfuhr, J.P., Toepfner, N., Steffen, G., Waldfahrer, F., & Berner, R. (2016). Clinical practice guideline: Tonsillitis I. Diagnostics and nonsurgical management. European Archives of Oto-Rhino-Laryngology, 273(4), 973–987. https://doi.org/10.1007/s00405-015-3872-6.

18. Bird, J.H., Biggs, T.C., & King, E.V. (2014). Controversies in the management of acute tonsillitis: An evidence-based review. Clinical Otolaryngology, 39(6), 368–374. https://doi.org/10.1111/coa.12299.

19. Abu Bakar, M., McKimm, J., Haque, S.Z., Majumder, M.A.A., & Haque, M. (2018). Chronic tonsillitis and biofilms: A brief overview of treatment modalities. Journal of Inflammation Research, 11, 329–337. https://doi.org/10.2147/JIR.S162486.

20. Alrayah, M. (2023). The prevalence and management of chronic tonsillitis: Experience from secondary care hospitals in Rabak City, Sudan. Cureus, 15(2), e34914. https://doi.org/10.7759/cureus.34914.

Downloads

Published

2025-12-15

Issue

Section

PEDIATRICS

How to Cite

HALITOSIS AS AN ADDITIONAL CLINICAL MARKER OF STREPTOCOCCAL TONSILLITIS IN CHILDREN: OUTPATIENT OBSERVATION. (2025). Actual Problems of Pediatrics, Obstetrics and Gynecology, 2, 90-99. https://doi.org/10.11603/24116-4944.2025.2.15820